DEXCOM INC·4

Jan 18, 8:21 PM ET

GREGG TERRANCE H 4

4 · DEXCOM INC · Filed Jan 18, 2018

Insider Transaction Report

Form 4
Period: 2018-01-16
GREGG TERRANCE H
DirectorPresident & CEO
Transactions
  • Sale

    Common Stock

    2018-01-16$56.86/sh10,000$568,58830,882 total(indirect: By Trust)
Holdings
  • Common Stock

    484,559
  • Common Stock

    (indirect: By IRA)
    11,461
Footnotes (3)
  • [F1]On December 5, 2017, Mr. Gregg adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Gregg. The shares set forth above were sold pursuant to the 10b5-1 Plan.
  • [F2]This transaction was executed in multiple trades at prices ranging from $56.44 and $57.36. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.
  • [F3]Shares are held by the Gregg Family Trust U/A/D 12/23/1998, with respect to which the reporting person is a trustee.

Documents

1 file
  • 4
    edgardoc.xmlPrimary

    PRIMARY DOCUMENT